HealthInvest Partners AB - SUPERNUS PHARMACEUTICALS INC ownership

SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 227 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.34 and the average weighting 0.1%.

Quarter-by-quarter ownership
HealthInvest Partners AB ownership history of SUPERNUS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2021$8,934,000
-45.3%
335,000
-36.8%
13.38%
-13.5%
Q2 2021$16,319,000
+16.7%
530,000
-0.7%
15.46%
+38.9%
Q1 2021$13,980,000
+19.5%
534,000
+14.8%
11.13%
+43.7%
Q4 2020$11,699,000
-13.9%
465,000
-13.6%
7.75%
-38.1%
Q4 2016$13,591,000
+44.8%
538,241
+41.8%
12.52%
+79.3%
Q3 2016$9,386,000
-29.9%
379,533
-42.3%
6.98%
+13.7%
Q2 2016$13,394,000
-2.8%
657,533
-27.2%
6.14%
-4.8%
Q1 2016$13,779,000
-2.5%
903,533
-14.1%
6.45%
-3.0%
Q4 2015$14,129,000
+28.7%
1,051,277
+34.3%
6.65%
+2.4%
Q3 2015$10,982,000782,7466.50%
Other shareholders
SUPERNUS PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
ASHFORD CAPITAL MANAGEMENT INC 698,676$41,816,0005.51%
Provident Investment Management, Inc. 543,194$32,510,0004.61%
NEUMEIER POMA INVESTMENT COUNSEL LLC 426,250$25,511,0002.37%
KOPP INVESTMENT ADVISORS LLC 41,879$2,506,0002.35%
AlphaOne Investment Services, LLC 126,279$7,558,0002.17%
Ranger Investment Management 468,933$28,066,0001.96%
Bruce & Co., Inc. 158,058$9,459,0001.88%
Penserra Capital Management LLC 244,371$29,030,0001.83%
SHAKER INVESTMENTS LLC/OH 49,642$2,971,0001.83%
Bridge City Capital, LLC 47,795$2,861,0001.81%
View complete list of SUPERNUS PHARMACEUTICALS INC shareholders